Danish pharmaceutical giant Novo beat market expectations in the third quarter. Sales of its weight-loss drug Wegovy, among other things, were stronger than expected.
BusinessSwedish pharmaceutical company Nanexa has entered into a licensing and collaboration agreement with Danish giant Novo worth just over SEK 13 billion, according to a press release.
BusinessHair loss could become weight-loss giant Novo's new cash cow.
BusinessDanish pharmaceutical giant Novo presents new goals for the coming year - and the stock market fell sharply.
BusinessDanish pharmaceutical giant Novo Nordisk is changing its name and logo, it has been confirmed to the Ritzau news agency.
BusinessThe foundation that owns the Danish pharmaceutical group Novo Nordisk - one of the world's leading manufacturers of weight-loss drugs - is investing in a new factory for the production of chips for quantum computers.
BusinessDespite a shaky commodity market and geopolitical unrest, virtually all major stock market indices are up for the first half of the year. But in Denmark, the numbers are flashing red.
BusinessShares in Danish pharmaceutical giant Novo Nordisk are plummeting on the Copenhagen Stock Exchange. A new research setback for the dieting giant – this time regarding Alzheimer's-fighting pills – is causing investors to hit the sell button.
Business
